Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils Edvardsson

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
The Patient|January 26, 2012
Pharmacological rhythm and rate control treatment for atrial fibrillation: patient and physician satisfactionNils Edvardsson, Anders Westlund, Margareta Thimell, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 18, 2014
Predictors of hospitalization for heart failure and of all-cause mortality after atrioventricular nodal ablation and right ventricular pacing for atrial fibrillationAnna Björkenheim, Axel Brandes, Tommy Andersson, et al.
Journal of Electrocardiology|June 28, 2011
DeltaT50--a new method to assess temporal ventricular repolarization variabilityChristina Abrahamsson, Corina Dota, Bo Skallefell, et al.
European Journal of Cardiovascular Nursing|November 19, 2003
Life situation related to the ICD implantation; self-reported uncertainty and satisfaction in Swedish and US samplesKärstin Bolse, Inger Flemme, Anita Ivarsson, et al.
Circulation|April 26, 2006
New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker featuresEllen Hoffmann, Neil Sulke, Nils Edvardsson, et al.
Clinical Drug Investigation|June 10, 2010
Effects of AZD0837, a novel direct thrombin inhibitor, on the electrophysiological properties of the human heart: a randomized, double-blind, parallel-group, placebo-controlled studyHåkan Walfridsson, Birgitta Johansson, Anders Englund, et al.
European Heart Journal|November 14, 2008
Rapid effects of air pollution on ventricular arrhythmiasPetter L S Ljungman, Niklas Berglind, Christina Holmgren, et al.
Frontiers in Pharmacology|March 18, 2020
The K<sub>Ca</sub>2 Channel Inhibitor AP30663 Selectively Increases Atrial Refractoriness, Converts Vernakalant-Resistant Atrial Fibrillation and Prevents Its Reinduction in Conscious PigsJonas Goldin Diness, Jeppe Egedal Kirchhoff, Tobias Speerschneider, et al.
Frontiers in Pharmacology|May 22, 2020
Inhibition of K<sub>Ca</sub>2 and K<sub>v</sub>11.1 Channels in Pigs With Left Ventricular DysfunctionCarlotta Citerni, Jeppe Kirchhoff, Lisbeth Høier Olsen, et al.
Journal of Electrocardiology|July 18, 2002
QRS aberration during atrial fibrillation at rest and during exercise. Effect of a selective potassium channel blocking agentBirgitta Houltz, Börje Darpö, Harry J G M Crijns, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
The Patient|January 26, 2012
Pharmacological rhythm and rate control treatment for atrial fibrillation: patient and physician satisfactionNils Edvardsson, Anders Westlund, Margareta Thimell, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 18, 2014
Predictors of hospitalization for heart failure and of all-cause mortality after atrioventricular nodal ablation and right ventricular pacing for atrial fibrillationAnna Björkenheim, Axel Brandes, Tommy Andersson, et al.
Journal of Electrocardiology|June 28, 2011
DeltaT50--a new method to assess temporal ventricular repolarization variabilityChristina Abrahamsson, Corina Dota, Bo Skallefell, et al.
European Journal of Cardiovascular Nursing|November 19, 2003
Life situation related to the ICD implantation; self-reported uncertainty and satisfaction in Swedish and US samplesKärstin Bolse, Inger Flemme, Anita Ivarsson, et al.
Circulation|April 26, 2006
New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker featuresEllen Hoffmann, Neil Sulke, Nils Edvardsson, et al.
Clinical Drug Investigation|June 10, 2010
Effects of AZD0837, a novel direct thrombin inhibitor, on the electrophysiological properties of the human heart: a randomized, double-blind, parallel-group, placebo-controlled studyHåkan Walfridsson, Birgitta Johansson, Anders Englund, et al.
European Heart Journal|November 14, 2008
Rapid effects of air pollution on ventricular arrhythmiasPetter L S Ljungman, Niklas Berglind, Christina Holmgren, et al.
Frontiers in Pharmacology|March 18, 2020
The K<sub>Ca</sub>2 Channel Inhibitor AP30663 Selectively Increases Atrial Refractoriness, Converts Vernakalant-Resistant Atrial Fibrillation and Prevents Its Reinduction in Conscious PigsJonas Goldin Diness, Jeppe Egedal Kirchhoff, Tobias Speerschneider, et al.
Frontiers in Pharmacology|May 22, 2020
Inhibition of K<sub>Ca</sub>2 and K<sub>v</sub>11.1 Channels in Pigs With Left Ventricular DysfunctionCarlotta Citerni, Jeppe Kirchhoff, Lisbeth Høier Olsen, et al.
Journal of Electrocardiology|July 18, 2002
QRS aberration during atrial fibrillation at rest and during exercise. Effect of a selective potassium channel blocking agentBirgitta Houltz, Börje Darpö, Harry J G M Crijns, et al.
Pageof 9